TCGA glioblastoma cases were classified into two categories: those with an alteration of the NF1 gene (i.e. mutation, deletion, or mRNA downregulation, N = 12) or no evidence of a deleterious NF1 alteration (N = 129). This evidence concerns the gene NF1 and glioblastoma.